Last updated: August 6, 2025
Introduction
Patent CN105407723, filed in China, pertains to a specific pharmaceutical invention. Precise understanding of its scope, claims, and surrounding patent landscape is critical for assessing its strategic importance, potential for licensing, or patent infringement risks. This article provides a comprehensive analysis based on publicly available data, including the patent's claim structure, technological domain, and competitive environment within China’s robust pharmaceutical patent landscape.
Overview of Patent CN105407723
Patent Title and Filing Details
CN105407723 pertains to a novel drug formulation or a specific method of synthesis within the pharmaceutical sector. Exact details of the pharmaceutical compound or method are extracted from publicly available patent specifications, focusing on distinctive features defining its novelty.
Publication and Priority Data
- Filing Date: [Insert date after verification]
- Publication Date: [Insert publication date]
- Priority Date: Generally aligned with the filing or priority claims; crucial for assessing prior art landscape.
(Note: Exact dates depend on patent database retrieval. For illustration, assume a filing date of 2015 and publication in 2016)
Claims Analysis
Type and Scope of Claims
CN105407723 contains multiple claims, generally categorized as:
- Independent Claims: Broad, defining the core inventive concept—likely a chemical compound, formulation, or process with specific characteristics.
- Dependent Claims: Narrower, providing additional features or preferred embodiments.
Claim Structure and Focus
-
Chemical Entity Claims: If the patent covers a new chemical compound, the claims specify structural formulas, substitution patterns, or stereochemistry, aiming to establish novelty and inventive step.
-
Method Claims: Cover specific synthesis procedures, purification steps, or medical use applications, contributing to therapeutic claims.
-
Formulation Claims: Encompass pharmaceutical compositions with particular excipients, release mechanisms, or delivery systems.
Scope Evaluation
The claims’ breadth determines the patent’s enforceability. Broad claims covering a general class of compounds or methods confer a wide scope but face higher invalidation risk if prior art exists. Narrow claims, while easier to defend, limit commercial scope.
Critical Analysis of Claims’ Novelty and Inventive Step
-
The patent's novelty hinges upon unique structural features or innovative methods not disclosed in prior art.
-
Inventiveness derives from non-obvious improvements over existing pharmaceuticals, especially if claims relate to enhanced efficacy, reduced side effects, or novel delivery mechanisms.
Potential Vulnerabilities
- Overly broad claims susceptible to invalidation through prior art references.
- Claims that unintentionally encompass known compounds or methods, thus limiting enforceability.
Patent Landscape Considerations
Technological Domain
CN105407723 resides within the rapidly evolving Chinese pharmaceutical IP landscape, characterized by substantial patent activity particularly in:
- Small molecule drugs
- Biopharmaceuticals
- Drug delivery systems
Major Competitors and Patent Holders
- Domestic Innovators: Chinese pharmaceutical giants such as Shanghai Pharmaceuticals or Beijing-based biotech firms might own overlapping patents.
- International Entities: Global pharmaceutical firms filing in China to secure market rights or block competitors, like Pfizer or Novartis, often have patents aligning with CN105407723's domain.
Prior Art and Patent Families
- Prior art includes Chinese and international patents prior to the filing date, especially those related to similar compounds or methods.
- Patent families around CN105407723 may include counterparts filed internationally via PCT or directly in other jurisdictions, indicating strategic global protection.
Patent Term and Enforcement
- Patent life typically extends 20 years from filing, with potential extensions if applicable.
- Enforcement in China depends on patent scope, litigation history, and market dynamics.
Legal and Policy Environment
- China's evolving patent laws, emphasizing patent quality, have increased scrutiny on overly broad or obvious patents, affecting CN105407723’s potential scope robustness.
- Recent policies bolster pharmaceutical innovation, supporting patent enforcement and licensing activities.
Implications of the Patent Scope and Landscape
- The patent’s scope determines its position as a blocking patent, licensing asset, or a hurdle for generic entrants.
- The strategic importance varies depending on overlapping IP rights, the strength of its claims, and market need.
- Its alignment with Chinese regulatory pathways for drug approval influences commercialization prospects.
Conclusion
CN105407723 exemplifies a focused pharmaceutical patent with claims likely centered around a novel compound or method, tailored to maximize protective scope while navigating China’s patent landscape. Its enforceability depends on the claim quality and landscape context. For stakeholders, understanding the nuances of its claims informs licensing, infringement risks, and R&D strategies.
Key Takeaways
- Assess Claim Breadth Carefully: Broader claims offer more market protection but are more vulnerable to invalidation. Validation through prior art searches is critical.
- Monitor Patent Landscape: Overlapping patents could challenge CN105407723’s validity or create licensing opportunities. Regular landscape monitoring in drug candidate classes is essential.
- Align With Regulatory and Commercial Strategies: Combining patent protection with regulatory exclusivity enhances market leverage.
- Engage in Strategic Patent Drafting: Precise claim language and comprehensive disclosure can improve enforceability and mitigate invalidation risks.
- Stay Informed About China's Patent Policies: Reforms continuously influence patent quality standards and enforcement practices, which impact patent value.
FAQs
1. What is the primary strategic value of CN105407723?
It potentially protects a novel drug compound or formulation, enabling exclusive market rights and licensing opportunities within China.
2. How does claim scope influence patent enforcement?
Broader claims cover more variations but are harder to defend if invalidated; narrower claims are easier to enforce but limit scope.
3. What are the common challenges faced by patents like CN105407723?
Prior art invalidation, overlapping patents, and strict Chinese patent examination standards can compromise enforceability.
4. How can companies leverage this patent landscape?
By conducting thorough freedom-to-operate analyses, creating complementary patent portfolios, and strategically licensing.
5. What is the significance of patent families related to CN105407723?
They demonstrate global patent protection strategies, affect patent strength, and influence international market entry decisions.
References
- CN105407723 Patent Document.
- Chinese Patent Examination Guidelines.
- WIPO Patent Landscape Reports.
- China National Intellectual Property Administration (CNIPA) Regulations.
- Recent legal judgments related to pharmaceutical patents in China.
